AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

TERIPARATIDE

7 registrations across 4 African markets— 7 active

Markets with TERIPARATIDE

🇿🇦South Africa
3 registrations
3 active
🇬🇭Ghana
2 registrations
2 active
🇳🇬Nigeria
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
MEGAPTH 250MG INJECTION [TERIPARATIDE (r-HUMAN PARATHYROID HORMONE) ]🇬🇭Ghana—activeApr 2030
MEGAPTH 250MG INJECTION [TERIPARATIDE (r-HUMAN PARATHYROID HORMONE) ]🇬🇭Ghana—activeApr 2030
INCRESCOTYDE🇿🇦South AfricaCipla Medpro (Pty) LtdactiveNov 2029
TERICRESCO🇿🇦South AfricaCipla Medpro (Pty) LtdactiveNov 2029
Osteotide Injection
Injection
🇳🇬NigeriaSJS Life Sciences LimitedactiveSept 2028
FORTEO🇿🇦South AfricaEli Lilly (S.A.) (Pty) LtdactiveJan 1900
BONSITY
Solution for Injection
🇹🇿TanzaniaSun Pharmaceutical Industries Ltdactive—

TERIPARATIDE in Africa — Regulatory Overview

TERIPARATIDE is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Nigeria, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.